Banguis, Maria Lourdes .

HRN: 26-08-64  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/03/2025
01/04/2025
IV
750
Q8
Ltcs
Waiting Final Action 
01/03/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/03/2025
01/04/2025
IV
500mg
Q8
Ltcs
Waiting Final Action 
01/03/2025
METRONIDAZOLE 500MG (TAB)
01/04/2025
01/08/2025
ORAL
500mg
Q8
Ltcs
Waiting Final Action 
01/03/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/03/2025
01/04/2025
IV
500mg
Q8
LTCS
Waiting Final Action 
01/04/2025
CO-AMOXICLAV 625MG (TAB)
01/04/2025
01/11/2025
PO
625mg
Q8
LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: